Polypharmacy and deprescribing: challenging the old and embracing the new.
作者信息
O'Donnell Lisa Kouladjian, Ibrahim Kinda
机构信息
Departments of Clinical Pharmacology and Ageing, Kolling Institute, Royal North Shore Hospital, Faculty of Medicine and Health, The University of Sydney, NSW, St Leonards, Australia.
Academic Geriatric Medicine, Faculty of Medicine, University Hospital Southampton, University of Southampton, Southampton, UK.
出版信息
BMC Geriatr. 2022 Sep 7;22(1):734. doi: 10.1186/s12877-022-03408-6.
Abstract
摘要
相似文献
1
Polypharmacy and deprescribing: challenging the old and embracing the new.
BMC Geriatr. 2022 Sep 7;22(1):734. doi: 10.1186/s12877-022-03408-6.
2
General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.
BMC Geriatr. 2021 Jan 7;21(1):19. doi: 10.1186/s12877-020-01953-6.
3
What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
BMC Geriatr. 2020 Oct 31;20(1):435. doi: 10.1186/s12877-020-01843-x.
4
The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy.
Sci Rep. 2021 Apr 26;11(1):8898. doi: 10.1038/s41598-021-88362-w.
5
The Role of Patient Preferences in Deprescribing.
Clin Geriatr Med. 2017 May;33(2):165-175. doi: 10.1016/j.cger.2017.01.004. Epub 2017 Feb 23.
6
Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
Am J Kidney Dis. 2017 Nov;70(5):611-618. doi: 10.1053/j.ajkd.2017.02.374. Epub 2017 Apr 14.
7
Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care - A cluster-randomised clinical trial.
BMC Geriatr. 2020 Nov 16;20(1):471. doi: 10.1186/s12877-020-01870-8.
8
The value of deprescribing in older adults with dementia: a narrative review.
Expert Rev Clin Pharmacol. 2021 Nov;14(11):1367-1382. doi: 10.1080/17512433.2021.1961576. Epub 2021 Aug 19.
9
Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.
BMC Fam Pract. 2019 May 14;20(1):64. doi: 10.1186/s12875-019-0953-4.
10
Patient values and preferences on polypharmacy and deprescribing: a scoping review.
Int J Clin Pharm. 2021 Dec;43(6):1461-1499. doi: 10.1007/s11096-021-01328-w. Epub 2021 Sep 22.
引用本文的文献
1
Exploring the Knowledge and Attitudes of Physicians on Polypharmacy and Deprescribing in Clinical Practice: a Cross-Sectional Study.
Maedica (Bucur). 2025 Jun;20(2):264-274. doi: 10.26574/maedica.2025.20.2.264.
2
Reframing Polypharmacy: Empowering Medical Students to Manage Medication Burden as a Chronic Condition.
Clin Pract. 2025 Jul 31;15(8):142. doi: 10.3390/clinpract15080142.
3
Implementation of medication reviews to optimize the use of medications in Swiss nursing homes: a mixed-methods study.
BMC Health Serv Res. 2025 Jul 8;25(1):943. doi: 10.1186/s12913-025-13042-8.
4
General polypharmacy, psychotropic polypharmacy, attitudes of patients on psychotropic deprescribing, and associated factors in adult psychiatric outpatients: a survey study in a comprehensive specialized hospital, northwest Ethiopia.
BMC Psychiatry. 2025 Apr 8;25(1):347. doi: 10.1186/s12888-025-06746-y.
5
Criteria to Report Adverse Drug Withdrawal Events in Clinical Trials: A Systematic Review.
J Am Geriatr Soc. 2025 Jun;73(6):1918-1928. doi: 10.1111/jgs.19457. Epub 2025 Mar 28.
6
The evidence and impact of deprescribing on sarcopenia parameters: a systematic review.
BMC Geriatr. 2025 Mar 7;25(1):158. doi: 10.1186/s12877-025-05819-7.
7
Severe Polypharmacy Increases Risk of Hospitalization Among Older Adults With Inflammatory Bowel Disease.
Am J Gastroenterol. 2025 Apr 1;120(4):844-855. doi: 10.14309/ajg.0000000000003036. Epub 2024 Aug 20.
8
'It's a job to be done'. Managing polypharmacy at home: A qualitative interview study exploring the experiences of older people living with frailty.
Health Expect. 2024 Feb;27(1):e13952. doi: 10.1111/hex.13952.
9
Exploring the Perceptions and Behaviours of UK Prescribers Concerning Novel Lipid-Lowering Agent Prescriptions: A Qualitative Study.
Pharmacy (Basel). 2024 Jul 3;12(4):104. doi: 10.3390/pharmacy12040104.
10
Antipsychotic Prescribing in Older Adults after In-Hospital Initiation.
Can J Hosp Pharm. 2024 May 8;77(2):e3543. doi: 10.4212/cjhp.3543. eCollection 2024.
Zotero 插件